Lifecore Biomedical stockholders elect nine directors and ratify KPMG at 2025 annual meeting

LIFECORE BIOMEDICAL, INC. DE

Katrina L. Houde, Humberto C. Antunes, Paul H. Johnson, Paul Josephs, Matthew E. Korenberg, Nelson Obus, Joshua E. Schechter elected by common and Series A holders.
Series A preferred stockholders elected Jason Aryeh and Christopher S. Kiper as directors with 38,776 votes for each.
Ratification of KPMG LLP as independent auditor for fiscal 2025 received 35,663,643 votes for, 15,326 against.
Non-binding advisory vote on named executive officer compensation approved with 24,642,130 votes for, 238,354 against.
A total of 37,436,784 common shares and 46,593 Series A preferred shares were outstanding on the record date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.